Philanthropy & Grantmaking
(T23)
990 on File
CHINA MEDICAL BOARD INC
Financial strength (30%)
62/100
Reliability (20%)
50/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$8.2M
Total Revenue
$14.6M
Total Expenses
$328.4M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.7%
Fundraising Efficiency
N/A
Operating Reserve
269.27x
Liability-to-Asset
0.2%
Revenue Diversification
44.0%
Executive Compensation
$829K
Compared with Peers
FY 2023
Compared with 1,312 similar organizations
(United States, Philanthropy & Grantmaking, $10M–$100M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
96.7% | 92.2% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
269.3 mo | 71.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.2% | 2.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
44.0% | 89.9% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-40.0% | 1.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
43.6% | 10.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-78.5% | -0.5% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $8.2M | $14.6M | $328.4M | 96.7% | — |
| 2022 | $13.7M | $10.2M | $330.6M | 92.5% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.